prof. MUDr. Jiří Mayer, CSc.
Department head, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 3643, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 1619
2021
-
miR-29-TRAF4 axis is a novel regulator of CD40 signaling in malignant B cells.
Year: 2021, type: Conference abstract
-
Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI
Leukemia, year: 2021, volume: 35, edition: 8, DOI
-
Molekulární a epidemiologická charakteristika Staphylococcus aureus dominujících v nemocničním prostředí pomocí HRM analýzy.
Year: 2021, type: Conference abstract
-
Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial
haematologica, year: 2021, volume: 106, edition: 12, DOI
-
Pacient-specifické systémy jako cesta ke sledování minimální zbytkové choroby u dalších pacientů s akutní myeloidní leukémií.
Year: 2021, type: Conference abstract
-
Palbociclib and ponatinib induce regression of acute myeloid leukemia in patient-derived xenograft model.
Year: 2021, type: Conference abstract
-
Patient-derived Xenograft Model of Chronic Lymphocytic Leukaemia Based on Mimicking Its Microenvironment.
Year: 2021, type: Conference abstract
-
Phosphorylation patterns of tumor suppressor P53 and their impact on the P53 pathway activity in chronic lymphocytic leukemia.
Year: 2021, type: Conference abstract
-
PI3KD inhibitor idelalisib snižuje hladiny CD20 u chronické lymfocytární leukémie inhibicí IL4-STAT6 signální dráhy.
Year: 2021, type: Conference abstract
-
Přímá mutační analýza genu TP53 bez nutnosti izolace DNA u vzorků periferní krve a kostní dřeně hematoonkologických pacientů.
Year: 2021, type: Conference abstract